LWP
NVAX icon

Laurel Wealth Planning’s Novavax NVAX Stock Holding History

Laurel Wealth Planning’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-99
Closed -$1.02K – 151
2022
Q4 		$1.02K Hold
99
– – ﹤0.01% 203
2022
Q3 		$2K Hold
99
– – ﹤0.01% 205
2022
Q2 		$5K Hold
99
– – ﹤0.01% 187
2022
Q1 		$7K Hold
99
– – ﹤0.01% 209
2021
Q4 		$14K Hold
99
– – 0.01% 130
2021
Q3 		$21K Hold
99
– – 0.02% 108
2021
Q2 		$21K Hold
99
– – 0.02% 79
2021
Q1 		$18K Hold
99
– – 0.02% 81
2020
Q4 		$11K Buy
+99
New +$10.5K 0.01% 79

Other funds holding NVAX

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Laurel Wealth Planning's NVAX Position: Q1 2023 in Review

Laurel Wealth Planning sold out of Novavax (NVAX) in Q1 2023, closing a stake of 99 shares — an estimated $1.02K sold.

Laurel Wealth Planning first reported a position in NVAX in Q4 2020 and held it in 9 quarters. The position peaked at $21K in Q3 2021. 222 funds tracked by Wall St. Rank hold NVAX as of Q1 2023.

  • Laurel Wealth Planning reported no remaining Novavax position as of Q1 2023 after selling out during the quarter.
  • Laurel Wealth Planning sold 99 Novavax shares in Q1 2023, an estimated $1.02K.
  • Laurel Wealth Planning first reported a position in Novavax in Q4 2020 and held it in 9 quarters.
  • Laurel Wealth Planning's Novavax position peaked at $21K in Q3 2021.
  • 222 funds tracked by Wall St. Rank held Novavax as of Q1 2023.

Based on Laurel Wealth Planning's 13F filing for Q1 2023, filed 18 Apr 2023.